Journals / Dicle Tıp Dergisi / 2013 / Cilt: 40 - Sayı: 3

The results of conjunctivolimbal autograft transplantation in primary pterygium

Primer pterjiumda konjonktivalimbal otogreft transplantasyonu sonuçlarımız

Pages
469–473
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the application sutures has more inflammation and irritation; although sutured economical method may be preferred due to the primary pterygium surgery is important one of the options.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the results of conjunctivolimbal autograft transplantation in the treatment of primary pterygium.
📊
Key Findings & Data:Methods: One hundred and forty-eight eyes of 140 patients with primary pterygium were included in the study.
💡
Conclusion & Impact:On the application sutures has more inflammation and irritation; although sutured economical method may be preferred due to the primary pterygium surgery is important one of the options.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the results of conjunctivolimbal autograft transplantation in the treatment of primary pterygium. Methods: One hundred and forty-eight eyes of 140 patients with primary pterygium were included in the study. Pterygium excision with sutured conjunctivolimbal autograft transplantation was performed to all of the eyes. Results: Eighty patients (57.1%) were male and 60 (42.9%) were female. The mean age of the patients was 48.5 ± 14.8 years (19-95). 2 (1.3%) in eyes with pterygium, which was located in the temporal, the other eyes with pterygium, which was located in the nasal. The mean follow up time was 21.1 ± 8.7 months (range 8-38). During the follow-up period infection of the sutures was observed 8 (5.4%) eyes and recurrence of the pterygium was observed in 4 (2.7%) eyes within six months after surgery. No other complications occurred. Conclusion: Conjunctivolimbal autograft transplantation has low recurrence and complication rate. İt can be said to be an effective method in primary pterygium. On the application sutures has more inflammation and irritation; although sutured economical method may be preferred due to the primary pterygium surgery is important one of the options.

Özet

Amaç: Primer pterjium tedavisinde konjonktivalimbal otogreft transplantasyonu sonuçlarını değerlendirmek. Yöntemler: Primer pterjiumu olan 140 hastanın 148 gözü çalışmaya dahil edildi. Tümüne pterjium eksizyonu ile sütürlü konjonktivalimbal otogreft transplantasyonu uygulandı. Bulgular: Hastaların 80i erkek (%57,1), 60ı kadın (%42,9) idi. Yaş ortalaması 48,5 ± 14,8 (19-95) yıl idi. İki (%1,3) gözde temporal yerleşimli olan pterjium diğer tüm hastalarda nazalde idi. Hastalar ortalama 21,1 ± 8,7 ay (8-38) takip edildi. Takipler sırasında 8 (% 5,4) gözde sütüre bağlı inflamasyon, 4 (%2,7) gözde nüks saptandı. Bunlar dışında hiçbir komplikasyona rastlanmadı. Nükslerin tamamı ilk 6 aylık takipte oluştu. Sonuç: Primer pterjiumda konjonktivalimbal otogreft transplantasyonunun düşük nüks ve komplikasyon oranı- na sahip, etkili bir yöntem olduğu söylenebilir. Sütürlü uygulama sütürlere bağlı inflamasyon ve irritasyonun fazla olmasına rağmen ekonomik bir yöntem olması nedeniyle primer pterjiumda tercih edilebilecek cerrahi seçeneklerden biridir.

🔖

Cite This Article

HARMANCI, Ç. (2013). The results of conjunctivolimbal autograft transplantation in primary pterygium. Dicle Tıp Dergisi, Cilt: 40 - Sayı: 3, 469–473. https://ajindex.com/articles/349026

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Touhami A, Di Pascuale MA, Kawatika T, et al. Characterization of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. Br J Ophthalmol 2005;89:269-274
  2. Jaros PA, Deluisa VP. Pinguecula and pterygia. Surv Ophthalmol 1988;33:41-49
  3. Duke-Elder SS. Diseases of The Outher Eye. System of Ophthalmology. G. Britain. The C.V. Mosby Company 1970;573-583
  4. Hilgers JHC. Pterygium: its insidence, heredity and etiology. Am J Ophtalmol 1960;50:635-644
  5. Ergin A, Bozdoğan Ö. Study on tear function abnormality in pterygium. Ophtalmologica 2001;215:204-208
  6. Dushku N, Hatcher SL, Albert DM, et al. P53 expression and relation to human papilloma virus infection in pinguecula, pterygia and limbal tumors. Arch Ophtalmol 1999;117:1593-1599
  7. Buratto L, Phillips RL, Carito G. Ptergium Surgery. Buratto L, Phillips RL, Carito G, eds.Thorofare, SLACK Inc.2000
  8. Oldenburg JB, Garbus J, McDonnell JM, et al. Conjunctival pterygia. Cornea 2000;9:200-204
  9. Sekeroglu H.T, Erdem E, Dogan NC, et al. “Sutureless amniotic membrane transplantation combined with narrow-strip conjunctival autograft for pterygium,” International Ophthalmology 2011;31:433-438
  10. Aslan L, Aslankurt M, Aksoy A, et al. Comparison of wide conjunctival flap and conjunctival autografting techniques in pterygium surgery. J Ophthalmol 2013;2013:209401
  11. Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997;115:1235-1240
  12. Xu Y, Zhou HM, Li J, et al. Efficacy of treatment for pterygium by autologous conjunctival transplantation and mitomycin C. Chin Med J 2012;125:3730-3734
  13. Arvas S, Öztürk M, Toparlak T ve ark. Pterjiyumlu olgularda ultrastrüktürel değerlendirme. T Oft Gaz 2002;32:88-93
  14. D’Ombrain A. The surgical treatment of pterygium. Br J Ophthalmol 1948;32:65-155
  15. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-1654
  16. Helal M, Messiha N, Amayem A, et al. intraoperative mitomycin C versus postoperative topical mitomycin C drops for the treatment of pterygium. Ophthalmic Surg Lasers 1996;27:674-678
  17. Ma DHK, See LC, Liau SB, et al. Amniotic membrane graft for primary pterygium:comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol 2000;84: 973-978
  18. Jiang J, Yang Y, Zhang M, et al. Compa